Načítá se...
Dabigatran: A New Anticoagulant for Stroke Prevention in Patients with Atrial Fibrillation
Ischemic stroke is arguably the most feared complication of atrial fibrillation. While warfarin has been the most effective pharmacologic treatment for stroke prevention in patients with nonvalvular atrial fibrillation, several limitations have led to its underutilization. Recently, dabigatran (Prad...
Uloženo v:
| Vydáno v: | Mo Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Journal of the Missouri State Medical Association
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6181744/ https://ncbi.nlm.nih.gov/pubmed/22675797 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|